Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population.

Fabián P Alvarez L Allard F Bianic Hélène Bricout Pascal Crépey J Gaillat Gaëtan Gavazzi A Mosnier Odile Launay M C LevantD ProshenskaCaroline de Courville

Published in: Journal of medical economics (2024)

Switching to QIV HD in older adults showed to be cost-effective, with even greater public health benefits at higher coverage rate, regardless the season severity.

Keyphrases

public health
high dose
physical activity
global health
low dose
affordable care act